NCT07741084

Brief Summary

The primary aim of the study is to compare stone free rates following ureteroscopic (URS) lithotripsy for renal stones with Thulium Fiber Laser (TFL) using a sheathless approach (low power laser settings) or using a flexible and navigable ureteral access sheath (FANS) with either low power or high power laser settings. Secondary aims are to compare the results of sheathless- and FANS assisted URS lithotripsy in terms of operative time, laser time, intraoperative and postoperative complications. Following the primary comparison between sheathless and FANS groups, another aim is to compare the outcome of low power and high power URS lithotripsy in the FANS patients with respect to operative time, SFR, laser time, intraoperative and postoperative complications. Patients ≥ 18 years with renal stones (8-25 mm) scheduled for URS lithotripsy at the Day Surgery Clinic at Haukeland University Hospital in Bergen, Akershus University Hospital and The Hospital of Vestfold - all renal stone centres in Norway, are eligible for inclusion in the study. After written consent and inclusion, patients are randomised to laser lithotripsy using one of three alternative ureteroscopic approaches: Group 1: Sheathless URS using low power TFL 4 -10 Watts, short pulse mode, Group 2: URS with FANS using low power TFL 4 - 10 Watts, short pulse mode or Group 3: URS with FANS using high power TFL 16 - 24 Watts, short pulse mode. The ureteroscopic procedures are performed in general anaesthesia using a standardised technique. All patients are followed up with a low dose CT scan 3 months post endoscopically to assess stone free status as well as a consultation at the outpatient clinic. Results and data for the three randomisation groups are compared according to the aims of the study.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
225

participants targeted

Target at P75+ for not_applicable

Timeline
11mo left

Started Aug 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 3, 2026

Completed
12 days until next milestone

Study Start

First participant enrolled

August 15, 2026

Expected
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2027

3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

August 3, 2026

Status Verified

July 1, 2026

Enrollment Period

8 months

First QC Date

July 28, 2026

Last Update Submit

July 28, 2026

Conditions

Keywords

URS lithotripsyTFLSheatless URSFANSlow power laser settingshigh power laser settings

Outcome Measures

Primary Outcomes (1)

  • Stone free rate

    Assessment of stone free status (or the presence of residual fragments) on low dose CT 3 months post endoscopically

    3 months post endoscopically

Secondary Outcomes (4)

  • Operative time

    During surgery (approximately 1 hour), registered immediately after surgery

  • Laser activation patterns: active laser time

    During surgery (approximately 1 hour), registered immediately after surgery

  • Intraoperative complications

    During surgery (approximately 1 hour), registered immediately after surgery

  • Postoperative complications

    After surgery until 3 months post endoscopically

Other Outcomes (5)

  • Operative time, FANS low power vs FANS high power

    During surgery (approximately 1 hour), registered immediately after surgery

  • Stone free rate, FANS low power vs FANS high power

    3 months post endoscopically

  • Laser activation patterns: active laser time, FANS low power vs FANS high power

    During surgery (approximately 1 hour), registered immediately after surgery

  • +2 more other outcomes

Study Arms (3)

Group 1 - Sheathless URS, low power

EXPERIMENTAL

Sheathless URS using low power laser settings (4-6W), short pulse: 0.4 - 0.5J at 10 or 20Hz, or 0.6 - 0.8J at 10Hz

Procedure: Sheathless URS

Group 2 - FANS, low power

EXPERIMENTAL

URS with FANS using low power laser settings (4-6W), short pulse: 0.4 - 0.5J at 10 or 20Hz, or 0.6 - 0.8J at 10Hz

Procedure: FANS, low power

Group 3 - FANS, high power

EXPERIMENTAL

URS with FANS using high laser power (16-24W), short pulse: 0.4 - 0.5J at 40Hz, 0.6J at 30 - 40Hz, or 0.8J at 20 - 30Hz

Procedure: FANS, high power

Interventions

Sheathless URS using low laser power (4-6W), short pulse: 0.4 - 0.5J at 10 or 20Hz, or 0.6 - 0.8J at 10Hz. Standard start-up settings: 0.4J/10Hz (4W)

Group 1 - Sheathless URS, low power

Sheathless URS using low laser power (4-6W), short pulse: 0.4 - 0.5J at 10 or 20Hz, or 0.6 - 0.8J at 10Hz. Standard start-up settings: 0.6J/10Hz (6W)

Group 2 - FANS, low power

URS with FANS using high laser power (16-24W), short pulse: 0.4 - 0.5J at 40Hz, 0.6J at 30 - 40Hz, or 0.8J at 20 - 30Hz. Standard start-up settings: 0.4J/40Hz (16W)

Group 3 - FANS, high power

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients ≥ 18 years scheduled for URS lithotripsy for renal stones, 8-25 mm, at the day surgery unit at Haukeland University Hospital, Akershus University Hospital and The Hospital of Vestfold

You may not qualify if:

  • Concomitant ureteral stone
  • Urinary diversion
  • Active infection
  • Untreated cancer in the upper urinary tract

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haukeland University Hospital

Bergen, Vestland, 5021, Norway

Location

Related Publications (2)

  • AEsoy MS, Juliebo-Jones P, Gjengsto P, Beisland C, Ulvik O. Watt's the difference? A randomised trial of high- vs low-power ureteroscopic thulium fibre laser lithotripsy. BJU Int. 2026 Mar;137(3):485-492. doi: 10.1111/bju.70123. Epub 2025 Dec 22.

    PMID: 41429432BACKGROUND
  • Ulvik O, AEsoy MS, Juliebo-Jones P, Gjengsto P, Beisland C. Thulium Fibre Laser versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. Eur Urol. 2022 Jul;82(1):73-79. doi: 10.1016/j.eururo.2022.02.027. Epub 2022 Mar 14.

    PMID: 35300888BACKGROUND

MeSH Terms

Conditions

Nephrolithiasis

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisMale Urogenital Diseases

Study Officials

  • Øyvind Ulvik

    Haukeland University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Øyvind Ulvik, MD, PhD, Professor

CONTACT

Mathias S Æsøy, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Stone free status is assessed on low dose CT 3 months post endoscopically by an outcome assessor blinded to the randomisation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The patients are randomised to ureteroscopic stone treatment with Thulium Fiber Laser with either a sheathless approach and low power laser settings, the use of FANS and low power laser settings or the use of FANS and high power laser settings. The ureteroscopic procedures are performed in a standardised manner and follow-up is similar in all three groups.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2026

First Posted

August 3, 2026

Study Start (Estimated)

August 15, 2026

Primary Completion (Estimated)

March 31, 2027

Study Completion (Estimated)

June 30, 2027

Last Updated

August 3, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Not allowed according to national regulations and ethical approval.

Locations